Literature DB >> 10387404

International comparisons of health care expenditures: what we know and what we do not know.

P Kanavos1, E Mossialos.   

Abstract

International comparisons of health care expenditures and their determinants have attracted considerable attention since the early 1960s and have since been used widely to compare countries. The impetus for this has been two-fold: firstly, to assess the macroeconomic efficiency of health systems by determining whether different methods of financing and delivering health care have contributed to the control of overall spending levels; and, secondly, to investigate the determinants of the level of health care expenditure. Empirical research has suggested that there is a causal and statistically significant relationship between growth in health spending and growth in gross domestic product (GDP), and that an increase in the latter brings about a proportionately larger increase in the former. This relationship holds even when other potential determinants, such as urbanisation and age structure of the population, are included in the analysis, leading to the conclusion that health care is a luxury good. This paper examines the extent to which this finding is valid from a methodological perspective and how far it assists policy analysis. We argue that there are significant problems in the measurement of health spending and GDP, discuss the methodological problems in the analysis and suggest that the observed relationship between GDP and health spending is unhelpful and almost certainly misleading for health policy development.

Mesh:

Year:  1999        PMID: 10387404     DOI: 10.1177/135581969900400211

Source DB:  PubMed          Journal:  J Health Serv Res Policy        ISSN: 1355-8196


  7 in total

1.  Understanding Differences in Health Care Spending: A Comparative Study of Prices and Volumes Across OECD Countries.

Authors:  Luca Lorenzoni; Sean Dougherty
Journal:  Health Serv Insights       Date:  2022-06-23

2.  Pharmaceutical market and health system in the Middle Eastern and Central Asian countries: Time for innovations and changes in policies and actions.

Authors:  Akbar Abdollahias; Shekoufeh Nikfar; Mohammad Abdollahi
Journal:  Arch Med Sci       Date:  2011-07-11       Impact factor: 3.318

3.  The Costs of Delivering Integrated HIV and Sexual Reproductive Health Services in Limited Resource Settings.

Authors:  Carol Dayo Obure; Sedona Sweeney; Vanessa Darsamo; Christine Michaels-Igbokwe; Lorna Guinness; Fern Terris-Prestholt; Esther Muketo; Zelda Nhlabatsi; Charlotte E Warren; Susannah Mayhew; Charlotte Watts; Anna Vassall
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

4.  Performance of UK National Health Service compared with other high income countries: observational study.

Authors:  Irene Papanicolas; Elias Mossialos; Anders Gundersen; Liana Woskie; Ashish K Jha
Journal:  BMJ       Date:  2019-11-27

5.  Cost-effectiveness analysis of stand-alone or combined non-invasive imaging tests for the diagnosis of stable coronary artery disease: results from the EVINCI study.

Authors:  Valentina Lorenzoni; Stefania Bellelli; Chiara Caselli; Juhani Knuuti; Stephen Richard Underwood; Danilo Neglia; Giuseppe Turchetti
Journal:  Eur J Health Econ       Date:  2019-08-13

6.  Delivering a primary-level non-communicable disease programme for Syrian refugees and the host population in Jordan: a descriptive costing study.

Authors:  Éimhín Ansbro; Sylvia Garry; Veena Karir; Amulya Reddy; Kiran Jobanputra; Taissir Fardous; Zia Sadique
Journal:  Health Policy Plan       Date:  2020-10-01       Impact factor: 3.344

7.  Cost-effectiveness of a structured medication review approach for multimorbid older adults: Within-trial analysis of the OPERAM study.

Authors:  Paola Salari; Cian O'Mahony; Séverine Henrard; Paco Welsing; Arjun Bhadhuri; Nadine Schur; Marie Roumet; Shanthi Beglinger; Thomas Beck; Katharina Tabea Jungo; Stephen Byrne; Stefanie Hossmann; Wilma Knol; Denis O'Mahony; Anne Spinewine; Nicolas Rodondi; Matthias Schwenkglenks
Journal:  PLoS One       Date:  2022-04-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.